Insider · CIK 0001227835

SARGEN GREGORY

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001227835

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	31,000
2025-06-12	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2025-02-05	Avid Bioservices, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−36.4K sh	—	—	0
2025-02-05	Avid Bioservices, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	49,305
2025-02-05	Avid Bioservices, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.6K sh	—	—	29,705
2025-02-05	Avid Bioservices, Inc.Stock Option right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.7K sh	—	—	10,030
2025-02-05	Avid Bioservices, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2025-02-05	Avid Bioservices, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−8,147 sh	—	—	0
2024-12-14	Avid Bioservices, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.8K sh	—	—	36,368
2024-12-14	Avid Bioservices, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.8K sh	—	—	0
2024-12-14	Avid Bioservices, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,147 sh	—	—	8,147
2024-06-07	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-12-14	Avid Bioservices, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,612 sh	—	—	9,612
2023-12-14	Avid Bioservices, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,612 sh	—	—	0
2023-12-14	Avid Bioservices, Inc.Restricted Stock UnitsA Award	Director	AAward	+26.8K sh	—	—	26,756
2023-06-07	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-04-11	Avid Bioservices, Inc.S Sale	Director	SSale	−7,011 sh	$20.24	−$142K	0
2022-12-14	Avid Bioservices, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,632 sh	—	—	7,011
2022-12-14	Avid Bioservices, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,632 sh	—	—	0
2022-12-14	Avid Bioservices, Inc.Restricted Stock UnitsA Award	Director	AAward	+9,612 sh	—	—	9,612
2022-06-08	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-12-14	Avid Bioservices, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,379 sh	—	—	2,379
2021-12-14	Avid Bioservices, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,379 sh	—	—	0
2021-12-14	Avid Bioservices, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,632 sh	—	—	4,632
2021-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-12-14	Avid Bioservices, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	124,305
2020-12-14	Avid Bioservices, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,379 sh	—	—	2,379
2020-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2020-01-10	TARAProtara Therapeutics, Inc.A Award	Director	AAward	+31K sh	—	—	31,000
2020-01-09	Avid Bioservices, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.7K sh	—	—	114,275
2019-12-04	CAMBREX CORPA Award	CFO & EVP, Corp. Dev.	AAward	+43.5K sh	—	—	165,925
2019-12-04	CAMBREX CORPS Sale	CFO & EVP, Corp. Dev.	SSale	−166K sh	$60.00	−$9.96M	0
2019-12-04	CAMBREX CORPM Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+20K sh	$53.60	+$1.07M	122,425
2019-12-04	CAMBREX CORPM Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+7,500 sh	$17.81	+$134K	39,925
2019-12-04	CAMBREX CORPM Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+15K sh	$41.36	+$620K	54,925
2019-12-04	CAMBREX CORPM Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+22.5K sh	$40.65	+$915K	77,425
2019-12-04	CAMBREX CORPM Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+25K sh	$45.63	+$1.14M	102,425
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+7,500 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+15K sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+22.5K sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+25K sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	CFO & EVP, Corp. Dev.	MExercise/Conversion	+20K sh	—	—	0
2019-02-15	CAMBREX CORPA Award	CFO & EVP, Corp. Dev.	AAward	+12K sh	—	—	38,227
2019-02-15	CAMBREX CORPS Sale	CFO & EVP, Corp. Dev.	SSale	−5,802 sh	$37.45	−$217K	32,425
2019-01-31	CAMBREX CORPA Award	CFO & EVP, Corp. Dev.	AAward	+6,227 sh	—	—	26,227
2018-12-14	Avid Bioservices, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	94,600
2018-10-24	CAMBREX CORPStock Option (right to buy)A Award	CFO & EVP, Corp. Dev.	AAward	+20K sh	—	—	20,000
2018-05-08	CAMBREX CORPA Award	CFO & EVP, Corp. Dev.	AAward	+7,500 sh	$16.91	+$127K	34,498
2018-05-08	CAMBREX CORPA Award	CFO & EVP, Corp. Dev.	AAward	+7,500 sh	$17.81	+$134K	41,998
2018-05-08	CAMBREX CORPA Award	CFO & EVP, Corp. Dev.	AAward	+15K sh	$41.36	+$620K	56,998

Recent filings

Accepted (ET)
Jun 164
SARGEN GREGORY0001213900-26-069247
SEC(opens sec.gov)
Jun 134
SARGEN GREGORY0001213900-25-054286
SEC(opens sec.gov)
Feb 74
SARGEN GREGORY0001683168-25-000862
SEC(opens sec.gov)
Dec 174
SARGEN GREGORY0001683168-24-008804
SEC(opens sec.gov)
Jun 104
SARGEN GREGORY0001213900-24-051379
SEC(opens sec.gov)
Dec 184
SARGEN GREGORY0001683168-23-008944
SEC(opens sec.gov)
Jun 84
SARGEN GREGORY0001213900-23-047469
SEC(opens sec.gov)
Apr 124
SARGEN GREGORY0001683168-23-002321
SEC(opens sec.gov)
Dec 164
SARGEN GREGORY0001683168-22-008498
SEC(opens sec.gov)

Companies

Address

C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR

NEW YORK, NY, 10010